KR900018367A - 마이코플라즈마를 함유한 세포배양물의 오염제거 방법 - Google Patents

마이코플라즈마를 함유한 세포배양물의 오염제거 방법 Download PDF

Info

Publication number
KR900018367A
KR900018367A KR1019900007513A KR900007513A KR900018367A KR 900018367 A KR900018367 A KR 900018367A KR 1019900007513 A KR1019900007513 A KR 1019900007513A KR 900007513 A KR900007513 A KR 900007513A KR 900018367 A KR900018367 A KR 900018367A
Authority
KR
South Korea
Prior art keywords
mycoplasma
cell cultures
treated
cultures containing
decontamination method
Prior art date
Application number
KR1019900007513A
Other languages
English (en)
Other versions
KR100220988B1 (ko
Inventor
랑그너 클라우스-디터
Original Assignee
스타인, 부크
베링베르케 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스타인, 부크, 베링베르케 아크티엔게젤샤프트 filed Critical 스타인, 부크
Publication of KR900018367A publication Critical patent/KR900018367A/ko
Application granted granted Critical
Publication of KR100220988B1 publication Critical patent/KR100220988B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/06Anti-neoplasic drugs, anti-retroviral drugs, e.g. azacytidine, cyclophosphamide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

내용 없음

Description

마이코플라즈마를 함유한 세포배양물의 오염제거 방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 첫단계에서 마이코플라즈마에 유효한 항생제로 처리하고 다음 단계에서 6-메틸푸린 데옥시리보사이드로 처리함을 특징으로하여, 마이코플라즈마를 함유하는 세포 배양물의 오염을 제거하는 방법.
  2. 제1항에 있어서, 사용된 항생제가 티아무린 및 미노사이클린인 방법.
  3. 제1항 또는 2항에 있어서, 6-메틸푸린 데옥시리보사이드가 50μM의 최종농도로 사용된 방법.
  4. 제1항 내지 3항중 어느 한 항에 있어서, 항생제 처리후 6-메틸푸린 데옥시리보사이드로 단일-클론배양물을 처리하는 방법.
  5. 제1항 내지 3항중 어느 한항에 따른 방법에 의해 생성된 마이코플라즈마-비함유 세포 배양물.
  6. 마이코플즈마-비함유 세포 배양물 제조를 위한, 제1항 내지 3항중 어느 한 항에 따른 방법의 용도.
  7. 제1항 내지 3항중 어느 한항에 있어서, 오염제거된 세포주가 사람 또는 동물로부터 유도된 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900007513A 1989-05-26 1990-05-24 마이코플라즈마를 함유하는 세포 배양물의 오염 제거방법 KR100220988B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE39171639 1989-05-26
DE3917163A DE3917163A1 (de) 1989-05-26 1989-05-26 Verfahren zur dekontamination mycoplasmenhaltiger zellkulturen

Publications (2)

Publication Number Publication Date
KR900018367A true KR900018367A (ko) 1990-12-21
KR100220988B1 KR100220988B1 (ko) 1999-10-01

Family

ID=6381444

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900007513A KR100220988B1 (ko) 1989-05-26 1990-05-24 마이코플라즈마를 함유하는 세포 배양물의 오염 제거방법

Country Status (12)

Country Link
US (1) US5902740A (ko)
EP (1) EP0399545B1 (ko)
JP (1) JP2934482B2 (ko)
KR (1) KR100220988B1 (ko)
AT (1) ATE121131T1 (ko)
AU (1) AU617052B2 (ko)
CA (1) CA2017568A1 (ko)
DE (2) DE3917163A1 (ko)
DK (1) DK0399545T3 (ko)
ES (1) ES2072331T3 (ko)
IE (1) IE66910B1 (ko)
PT (1) PT94145B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102368575B1 (ko) 2021-08-17 2022-02-28 주식회사 퀀텀바이오닉스 항 마이코플라즈마 기능을 제공하는 배양용기 및 그 제조방법

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007222155A (ja) * 2006-01-27 2007-09-06 Shinshu Univ ヒトリンパ管由来細胞株およびそれを用いた診断キット
DE102018003906A1 (de) * 2018-05-07 2019-11-07 Smart Material Printing Verwendung von Polyoxometallaten gegen den Befall von Eukaryotenkulturen, Virenkulturen und Mikroorganismenpopulationen durch Mollicuten sowie mollicutenhemmende und -abtötende polyoxometallathaltige Stoffe und Verfahren
CN111117962A (zh) * 2019-12-24 2020-05-08 武汉博士德生物工程有限公司 一种有效去除支原体污染的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4387161A (en) * 1981-07-16 1983-06-07 Institute For Medical Research Detection of mycoplasma infection in cell cultures
DE3617803A1 (de) * 1985-11-07 1987-11-19 Bayer Ag Verwendung von gyrasehemmern zur dekontamination von mycoplasma-infizierten zellkulturen
JP2709604B2 (ja) * 1988-06-29 1998-02-04 大日本製薬株式会社 マイコプラズマ汚染の防止または除去

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102368575B1 (ko) 2021-08-17 2022-02-28 주식회사 퀀텀바이오닉스 항 마이코플라즈마 기능을 제공하는 배양용기 및 그 제조방법

Also Published As

Publication number Publication date
DK0399545T3 (da) 1995-08-14
EP0399545A3 (de) 1991-01-02
CA2017568A1 (en) 1990-11-26
PT94145A (pt) 1991-01-08
AU5590090A (en) 1990-11-29
DE59008875D1 (de) 1995-05-18
IE66910B1 (en) 1996-02-07
ES2072331T3 (es) 1995-07-16
ATE121131T1 (de) 1995-04-15
PT94145B (pt) 1996-12-31
AU617052B2 (en) 1991-11-14
IE901893L (en) 1990-11-26
DE3917163A1 (de) 1990-12-06
EP0399545B1 (de) 1995-04-12
US5902740A (en) 1999-05-11
KR100220988B1 (ko) 1999-10-01
JPH03130074A (ja) 1991-06-03
DE3917163C2 (ko) 1991-04-25
JP2934482B2 (ja) 1999-08-16
EP0399545A2 (de) 1990-11-28

Similar Documents

Publication Publication Date Title
ATE80803T1 (de) Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl.
ATE235262T1 (de) Verfahren zum sterilisieren von produkten
AU547408B2 (en) Sterilization process using hydrogen peroxide followed by neutralisation of residue
DE3886254T2 (de) Apparat zur Behandlung von biologischen Proben und Behandlungsmethoden mit dem Apparat.
ES2032316T3 (es) Procedimiento para la esterilizacion de plasma o fracciones de plasma.
SE8803071D0 (sv) Bakteriebehandling for att bevara hokvalitet genom att tillegga genius bacillus mikroorganismer
ATE242960T1 (de) Vorrichtung und verfahren zur photoaktivierung
BR8806580A (pt) Processo e aparelho para tratamento de solucao esteril e sistema de recuperacao eletroquimica
KR900018367A (ko) 마이코플라즈마를 함유한 세포배양물의 오염제거 방법
SE8801511D0 (sv) Avfettningsforfarande och anordning derfor
DE59309822D1 (de) Anaerobe Behandlung stark fetthaltiger Substanzen
DE58902416D1 (de) Verfahren zur sterilisierung von teilchenfoermigen pharmazeutischen substanzen.
AT330108B (de) Verfahren zur warmebehandlung, insbesondere zur sterilisation oder desinfektion, von wasserhaltigen schlammen und vorrichtung zur durchfuhrung des verfahrens
DK445987A (da) Swalpamycin, fremstilling deraf og dets anvendelsesom laegemiddel, samt ved fremstillingen anvendelig mikroorganisme
GB2000968A (en) Killed trypanosoma vaccine and immunologically active components of trypanosoma
MX9708027A (es) Metodo para la descontaminacion microbiana de plaquetas sanguineas.
DE69433851D1 (de) Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv
SU936617A1 (ru) Способ инактивации возбудителя чумы
FR2528704B1 (fr) Procede et appareil de sterilisation
FI883226A (fi) Kontrollindikator foer gassterilisering.

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

S901 Examination by remand of revocation
GRNO Decision to grant (after opposition)
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee